Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Negative pressure dressings after emergency midline laparotomy

Official title: Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy

Run by Uppsala University · NCT07003906 · Data updated 2026-11-12

This trial will test whether using negative pressure wound therapy on adults having emergency midline laparotomy lowers wound complications compared with standard dressings.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment720 (estimated)
SponsorUppsala University
Academic / other
Locations6 sites (Eskilstuna and 5 other locations)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedDecember 2028
Study endsDecember 2035
Registry record updatedJuly 7, 2026
Trial IDNCT07003906 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) who can give informed consent, undergo emergency midline laparotomy with primary skin closure and an incision longer than 10 cm, and can attend follow-up visits are eligible.

Probably not a fit

Patients who are pregnant or breastfeeding, allergic to dressing materials, expected to need reoperation within 28 days, had an emergency laparotomy within the past 3 months, or cannot be followed up are unlikely to benefit from joining this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing emergency midline laparotomy with a primary skin closure and an incision longer than 10 cm are randomized 1:1 at skin closure to receive either a negative pressure wound therapy dressing or a standard postoperative dressing. No other aspects of perioperative care are changed, and patients are followed at 7, 30, and 365 days with two in-person visits, surveys, and an optional CT scan to check for incisional hernia. The primary outcome is the rate of wound complications (surgical site infection, wound dehiscence, seroma), with secondary outcomes including length of stay, peri-wound blistering, and patient satisfaction. The goal is to determine whether NPWT reduces early and late wound complications after emergency laparotomy.

Why it matters

Potential benefit: If successful, NPWT could reduce surgical site infections, wound breakdown, seroma formation, and possibly lower hernia rates and shorten recovery after emergency laparotomy.

How similar studies have gone: Similar NPWT approaches have shown benefit in some elective and high‑risk abdominal wound studies, but their effectiveness specifically after emergency laparotomy is less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥18 years old
* Written informed consent
* \>10 cm midline incision with primary skin closure
* Emergency laparotomy

Exclusion Criteria:

* Not able to consent (e.g. dementia, impaired cognitive function, unconscious)
* Subjects not possible to follow up as assessed by the Investigator
* Allergy to dressing material
* Pregnancy or breastfeeding (females of childbearing potential)
* Previous enrolment in the current study
* Expected reoperation with 28 days of index laparotomy
* Emergency laparotomy within 3 months

Where it's running

  • Linköping University Hospital
    Linköping, Sweden
    Recruiting
  • Mora Hospital
    Mora, Sweden
    Recruiting
  • Vrinnevi Hospital
    Norrköping, Sweden
    Recruiting
  • Uppsala University Hospital
    Uppsala, Sweden
    Recruiting
  • Västmanlands Hospital Västerås
    Västerås, Sweden
    Recruiting
  • Mälar Hospital
    Eskilstuna, Sweden
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.